BMRA
Price
$2.98
Change
-$0.22 (-6.88%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
9.18M
Intraday Buy/Sell Signals
NVCR
Price
$13.85
Change
-$0.28 (-1.98%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.58B
8 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BMRA vs NVCR

Header iconBMRA vs NVCR Comparison
Open Charts BMRA vs NVCRBanner chart's image
Biomerica
Price$2.98
Change-$0.22 (-6.88%)
Volume$100
Capitalization9.18M
NovoCure
Price$13.85
Change-$0.28 (-1.98%)
Volume$18K
Capitalization1.58B
BMRA vs NVCR Comparison Chart in %
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRA vs. NVCR commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRA is a Hold and NVCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 23, 2025
Stock price -- (BMRA: $3.20 vs. NVCR: $14.13)
Brand notoriety: BMRA and NVCR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BMRA: 14% vs. NVCR: 67%
Market capitalization -- BMRA: $9.18M vs. NVCR: $1.58B
BMRA [@Medical/Nursing Services] is valued at $9.18M. NVCR’s [@Medical/Nursing Services] market capitalization is $1.58B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $221.98B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRA’s FA Score shows that 1 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • BMRA’s FA Score: 1 green, 4 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMRA and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRA’s TA Score shows that 4 TA indicator(s) are bullish while NVCR’s TA Score has 5 bullish TA indicator(s).

  • BMRA’s TA Score: 4 bullish, 3 bearish.
  • NVCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BMRA is a better buy in the short-term than NVCR.

Price Growth

BMRA (@Medical/Nursing Services) experienced а +11.11% price change this week, while NVCR (@Medical/Nursing Services) price change was +7.29% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.94%. For the same industry, the average monthly price growth was +0.63%, and the average quarterly price growth was +15.50%.

Reported Earning Dates

NVCR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.94% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.58B) has a higher market cap than BMRA($9.18M). BMRA YTD gains are higher at: 33.289 vs. NVCR (-52.584). BMRA has higher annual earnings (EBITDA): -4.71M vs. NVCR (-110.77M). NVCR has more cash in the bank: 912M vs. BMRA (3.06M). BMRA has less debt than NVCR: BMRA (543K) vs NVCR (700M). NVCR has higher revenues than BMRA: NVCR (630M) vs BMRA (5.68M).
BMRANVCRBMRA / NVCR
Capitalization9.18M1.58B1%
EBITDA-4.71M-110.77M4%
Gain YTD33.289-52.584-63%
P/E RatioN/AN/A-
Revenue5.68M630M1%
Total Cash3.06M912M0%
Total Debt543K700M0%
FUNDAMENTALS RATINGS
BMRA vs NVCR: Fundamental Ratings
BMRA
NVCR
OUTLOOK RATING
1..100
3473
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5760
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRA's Valuation (32) in the Medical Specialties industry is significantly better than the same rating for NVCR (100). This means that BMRA’s stock grew significantly faster than NVCR’s over the last 12 months.

BMRA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that BMRA’s stock grew similarly to NVCR’s over the last 12 months.

BMRA's SMR Rating (98) in the Medical Specialties industry is in the same range as NVCR (98). This means that BMRA’s stock grew similarly to NVCR’s over the last 12 months.

BMRA's Price Growth Rating (57) in the Medical Specialties industry is in the same range as NVCR (60). This means that BMRA’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for BMRA (100). This means that NVCR’s stock grew significantly faster than BMRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRANVCR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 20 days ago
75%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AFBI18.680.07
+0.38%
Affinity Bancshares
NATL37.940.03
+0.08%
NCR Atleos Corp
TSN52.35-0.13
-0.25%
Tyson Foods
CPAC7.23-0.02
-0.27%
Cementos Pacasmayo SAA
XBIO3.87-0.23
-5.61%
Xenetic Biosciences

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with ITGR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
-2.42%
ITGR - NVCR
42%
Loosely correlated
+0.53%
BLFS - NVCR
39%
Loosely correlated
-0.65%
ALGN - NVCR
38%
Loosely correlated
+0.96%
AZTA - NVCR
38%
Loosely correlated
+0.76%
ENOV - NVCR
37%
Loosely correlated
-0.49%
More